Filter
1584
Filtered Results: 1584
Text search:
diagnóstico
molecular
Featured
Recommendations
183
New Publications
291
Language
Document type
No document type
716
Guidelines
380
Studies & Reports
249
Manuals
89
Strategic & Response Plan
74
Fact sheets
39
Training Material
15
Situation Updates
12
Resource Platforms
6
Infographics
3
Brochures
1
Countries / Regions
India
77
Latin America and the Carribbean
66
Western and Central Europe
54
Brazil
52
Global
46
Africa
38
Eastern Europe
35
Colombia
29
Kenya
25
Argentina
23
Senegal
22
Peru
21
South Africa
21
Tanzania
19
West and Central Africa
19
Ethiopia
19
El Salvador
17
East and Southern Africa
17
Venezuela
16
Germany
16
Russia
16
Mozambique
15
Paraguay
14
Congo, Democratic Republic of
13
Rwanda
11
Chile
11
Malawi
11
Uganda
11
Sierra Leone
10
Nigeria
10
South–East Asia Region
10
Bolivia
10
Cameroon
9
Philippines
9
Asia
9
Angola
9
Zambia
9
Ecuador
9
Ukraine
8
Burkina Faso
8
Liberia
8
Bangladesh
7
Ghana
6
Middle East and North Africa
6
Nepal
5
Benin
5
Zimbabwe
5
Guinea
5
Haiti
5
Eastern Europe and Central Asia
5
Spain
5
Namibia
5
Madagascar
5
USA
4
Western Pacific Region
4
France
4
Côte d’Ivoire / Ivory Coast
4
Indonesia
4
Myanmar / Burma
4
Uruguay
3
Mali
3
Eswatini/ Swaziland
3
Syria
2
Congo-Brazzaville
2
Niger
2
Cambodia
2
Dominican Republic
2
Guinea-Bissau
2
North America
2
Lebanon
2
Georgia
2
Honduras
2
Chad
2
Pakistan
2
Guatemala
2
Tajikistan
1
Timor Leste/ East Timor
1
Thailand
1
Mexico
1
Lesotho
1
Turkey
1
Gambia
1
Togo
1
China
1
Canada
1
Estonia
1
Burundi
1
Morocco
1
Mauritania
1
Italy
1
Jordan
1
Saudi Arabia
1
Luxembourg
1
Turkmenistan
1
Belgium
1
United Kingdom
1
Portugal
1
Nicaragua
1
Djibouti
1
Romania
1
Palestine
1
Central African Republic
1
Libya
1
Botswana
1
Iraq
1
Somalia
1
Cuba
1
Authors & Publishers
Publication Years
Category
Guidelines
176
Policies & Guidelines HIV & TB
148
COVID-19
142
Studies & Reports
92
Policies
66
TB
63
Disease Prevention & Control
29
Drugs & Medical Equipment
25
Statistics
23
Women & Child Health
22
Malaria
21
Virology
20
Pediatrics
17
Bacteriology
15
Capacity Building
15
Non-communicable Diseases
13
Hepatitis
12
General Guidelines
12
HIV & STI
12
Vaccine-preventable Diseases
11
Communicable Diseases
10
Countries
10
NTDs & Others
9
Parasitology
9
Vector Control
8
Chagas
8
Yellow Fever
8
Community Health
8
Cancer
7
Communicable Diseases
7
Paediatrics
6
Monitoring & Evaluation
6
Medical Devices & Equipment
6
Dengue
6
Leishmaniasis
6
Diabetes
5
MPOX - Monkeypox
5
Hemorrhagic Fever
5
Quality Control & Assurance
5
Reproductive Health
5
Rabies
4
Breast Cancer
4
Cancer Treatment & Resources
4
Diarrhoeal Disease/Cholera
4
Clinical Guidelines
4
Information, Education and Communication (IEC)
4
Humanitarian Crisis
4
Health Systems
4
Yaws
3
Cervical Cancer
3
Infection Control & Prevention (IPC)
3
Yersinia pestis (Plague)
3
Other
3
Radiology and Diagnostic
3
Public Health
2
Pharmacy & Technology
2
Child Health
2
Buruli Ulcer
2
Disaster Preparedness
2
Community Health
2
Public Health
2
NCD
2
Cardiovascular Diseases
2
Demograhic Health Surveys DHS
2
Respiratory Infections
2
Immunization
2
Surgery & Anaesthesia
2
General Guidelines
2
Needs Assessment
2
Gynaecology & Obstetrics
2
Protection & Security
2
Women & Child Health
2
Maternal Health
2
Laboratory Technologies
2
Laboratory Quality Assurance
2
Age & Elderly
2
Key Resources
2
Zika
1
Sanitation
1
Hand Hygiene
1
Project Cycle Management
1
Taeniasis/ Cysticercosis
1
Schistosomiasis
1
Dermatology
1
Other Cancer diseases
1
Pediatric cancer
1
Emergency Care
1
IEC Material
1
Snakebites
1
Palliative Care
1
Mental Health
1
COPD/Asthma
1
Human African Trypanosomiasis
1
Neonatal Care
1
Toolboxes
Country specific documents
96
Diagnostics & Laboratory Guidance
66
Detection & Diagnosis
59
Clinical Guidelines
49
Prevention & Control
43
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
38
Children/Adolescents Mental Disorders
36
Drug resistant TB
35
Country specific
33
Adults
33
TB/HIV Coinfection
22
Surveillance & Contact tracing
20
Surveillance
17
Reports
16
TB & Prisoners
15
Training
15
Children
14
Colombia
14
International
13
Essential Medicines & Devices Lists
13
Eastern Europe & Central Asia
13
Laboratory
12
General
12
Infection Control General
12
Reports & Studies
12
Agriculture & Veterinary
11
Genomic sequencing
11
Brazil
11
El Salvador
11
Disease Prevention & Control
11
SEAR (South-east Asia Region)
11
HIV testing & services
10
General
10
TB/COVID-19
10
Research & Access
10
AmR (Region of Americas)
10
Policies & Strategies
9
Surveillance
9
Influenza Prevention & Control
9
Public Health
9
TB & Other Vulnerable Populations
9
Laboratory & Sampling
9
Global Impact: Socio-economic, health services, TB & HIV
9
General documents One Health
9
Clinical Aspects & Diagnostics
9
Testing Guidelines
9
Laboratory Guidance
8
Children & Adolescents
8
Treatment Guidelines
8
Prevention & Preparedness
8
Advocacy & Communication
8
Studies & Reports
8
Overview, Studies & Reports
8
General
8
Policies and guidelines
8
Neurological Disorders
8
Biosafety
7
Childhood TB
7
Moldova
7
Context & Facts, Travel Advice
7
Paediatrics
7
Hospital Readiness/Essential Health Services
7
SARS-CoV-2 Variants
7
Peru
7
Other Countries
7
Zoonoses
7
Studies & Reports
7
Germany
7
Latin America & the Carribean
7
Outbreak Prevention & Control
6
Gynaecology / Obstetrics
6
Opportunistic Infections
6
TB
6
Laboratory
6
Clinical Guidelines
6
Country Specific
6
Essential Medicines & Medical Devices
6
Long COVID/ Post-COVID Syndrome
6
Rational use of Medicine
6
Studies & Reports
6
Clinical Guidelines
6
TB
6
Laboratory & Diagnostics
6
Eastern Europe and central Asia
6
Assessment & Studies
5
Meningitis Prevention & Control
5
Clinical Aspects, Treatment & Prevention
5
Yellow Fever Prevention & Control
5
Surveillance
5
Research
5
Context & Facts
5
Studies
5
Appeals and Response Plans
5
Access & Strategy
5
Immunization Guidelines
5
Argentina
5
MPOX - Monkeypox
5
Chagas
5
Clinical Aspects & Diagnostics
5
Clinical Aspects & Diagnostics
5
Romania
5
Assessment
5
Chikungunya Prevention & Control
5
Zika Prevention & Control
5
Neurological disorders, Others
5
ART Drug Resistance
4
IPC
4
Azerbaijan
4
Policies & Strategies
4
Treatment & Prevention
4
Clinical Aspects
4
Hepatitis
4
HIV
4
Attention deficit hyperactivity disorder (ADHD)
4
Ethiopia
4
Infection Prevention & Hygiene
4
For General Public & Community
4
For Health Worker
4
Scientific & Research Studies
4
Physical Distancing
4
Overview
4
Chile
4
Ecuador
4
HIV &TB
4
Pharmacovigilance
4
MPOX - Monkeypox
4
Clinical Aspects & Diagnostics
4
Studies & Reports
4
Yaws & other Endemic Treponematoses
4
Access to treatment and laboratory
4
Prevention & Strategies
4
Studies & Reports
4
Autism
4
Dengue Prevention & Control
4
Western & Central Europe
4
Preparedness & Prevention
4
Kenya
4
Public Health
4
Plague Prevention & Control
4
Preparedness & Prevention
4
Vaccines & Immunization
3
Yellow Fever
3
Treatment Guidelines HIV
3
Namibia
3
Vaccination
3
Georgia
3
Drug resistance
3
Russia
3
Supporting tools
3
For Pregnant Women
3
Human Rights
3
For Older People
3
Gender Aspects
3
Blood Supply
3
Long-term Care Facilities
3
TB/HIV
3
COVAX Initiative
3
Essential Medicines
3
One Health
3
General Guidelines for Rational Use
3
Studies & Reports
3
Studies & Reports
3
Leptospirosis
3
Women
3
Clinical Guidelines
3
Ghana
3
Bipolar Affective Disorders
3
General
3
National Emergency Response Plans
3
Prophylactic Treatment
3
Roadmaps, Action Plans & Policies
3
HIV and coinfection
3
Nigeria
3
General Reports
2
Ebola Prevention & Control
2
Background PTSD in children
2
Ukraine
2
South Africa
2
WPRO (Western Pacific Region)
2
Prevention Guidelines
2
Influenza
2
Dengue
2
Measures ICF/ Model Disability Survey
2
Eastern Mediterranean Region
2
National Policies
2
Stroke
2
Rwanda
2
Prophylaxis
2
Clinical aspects
2
Country Guidelines
2
Communication & Training
2
Climate & Health
2
Clinical Guidelines
2
COVID-19
2
Clinical Aspects
2
Information Material &Training
2
Public Health
2
Training, others
2
Prison & Detention
2
HIV and COVID-19
2
Latin America
2
Situation Reports COVID-19
2
Non-pharmaceutical interventions (NPIs)
2
Ebola Treatment Center
2
Logistics & Supply
2
Moderna
2
Biontech/Pfizer Comirnaty
2
Research & Pipeline
2
Estonia
2
Latin America
2
Falsified & Substandard
2
Pharmacy Practice
2
Public Health
2
Prevention & Measures
2
Antimicrobial Resistance (AMR)
2
Others
2
WASH Water Sanitation & Hygiene
2
Health Impact & Climate Change
2
MPOX -Monkeybox Prevention & Control
2
Clinical Aspects & Diagnostics
2
Clinical Aspects & Diagnostics
2
Information & Education Material (IEC)
2
Statistics & Facts
2
Statistics & Facts
2
Taeniasis/Cysticercosis
2
General Information & Methodology
2
Health Financing Toolbox
2
Studies & Reports
2
Co-Morbidities (except TB)
2
Substance Use Disorders & Addiction
2
Zika
2
Malawi
2
TB/HIV Global
2
Tuberculosis
2
Nutrition
2
Prevention of mother-to-child transmission (PMTCT)
2
Uganda
2
Stewardship
2
General Public
2
Antiretroviral Treatment ART
2
Infection Control
2
Context & Facts
2
Meningitis & Encephalitis
2
Africa
1
War & Conflict
1
Rapid Response
1
Alcohol
1
Natural Disaster
1
Clinical Guidelines
1
Health Systems
1
Treatment Guidelines
1
Clinical Guidelines
1
Intellectual Disability
1
TB & Drug Abuse
1
Children with Disabilities
1
Posttraumatic stress disorder Adults
1
Guillain-Barré Syndrome
1
Hand Hygiene
1
Preparedness, Response & Risk Communication
1
Clinical Guidelines
1
Vector Control
1
Key Resources
1
HIV surveillance
1
Clinical Guidelines
1
Zambia
1
Policies & Programmes
1
Plague
1
Substance Use Disorders, Others
1
Schizophrenia
1
Policies
1
Infection Control
1
Platforms and initiatives
1
Wheelchair Service and Management
1
Drug resistance
1
Eastern Europe
1
Stigma & Discrimination
1
General Studies & Reports
1
Tools for Rational use
1
Cholera Prevention & Control
1
Global
1
Training Material
1
SOPs
1
African Region
1
Preparedness, Response & Risk Communication
1
Mozambique
1
Standard Precautions
1
Ebola
1
Training Supporting Material mhGAP
1
Public Health
1
Child Health / Pediatrics
1
Microcephaly
1
Workplace
1
Manual & Leaflet
1
Epilepsy
1
Belarus
1
Posttraumatic Stress Disorder in Children
1
HIV / AIDS
1
Sustainable Development Goals
1
IEC Substance Use Disorders
1
DR Congo
1
Cannabis
1
Situation Reports & Updates
1
Health Personnel
1
Livestock production
1
Hand Hygiene
1
Risk Communication & Community Engagement
1
Covid-19 & the One Health Approach
1
COVID-19
1
Faith-based Organizations
1
For Migrants & Refugees
1
Protection of Vulnerable Groups
1
Educational Settings
1
Workplace
1
LGBTI*
1
Infection Control & Prevention (IPC)
1
Oxygen Therapy
1
Vaccine Candidates & Research
1
Fair Allocation & Ethical Aspects
1
Vaxzevria (Astra Zeneca)
1
Standard Operating Procedure (SOP)
1
Others
1
Hand Hygiene
1
Sanitation
1
Others
1
Studies & Reports
1
Nurses
1
Palliative Care
1
Booster Doses
1
Overview & reports
1
Prices and Patents
1
Traditional & Herbal Medicines
1
Pediatrics
1
Cancer
1
Intensive Care Unit
1
Guiding documents and principles
1
Epilepsy
1
Waste Managment
1
Health Care Systems
1
Infectious Diseases
1
More Clinical Guidelines on Palliative Care
1
Health Care In Conflict Settings
1
NTDs
1
Leishmaniasis
1
Information & Education Material (IEC)
1
Statistics & Facts
1
Statistics & Facts
1
Statistics & Facts
1
Statistics & Facts
1
NTDs General
1
Vector control
1
Policies & Strategies
1
Other NTDs
1
Dracunculiasis (guinea-worm disease)
1
Echinocccosis
1
Mycetoma, Chromoblastomycosis & other deep mycosis
1
Onchocerciasis
1
Scabies
1
Prevention & Strategies
1
Statistics & Facts
1
Clinical Aspects & Diagnosis
1
Studies & Reports
1
Others
1
Armenia
1
Clinical Aspects & Diagnosis
1
Global Overview
1
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
1
Asia
1
Children's Rights
1
Asia and Pacific
1
War Surgery & Wound Care
1
Training Material
1
General
1
Clinical Guidelines
1
Alzheimer's Disease & Dementia
1
Assistive devices & technologies
1
General Aspects
1
Protection
1
Regional Reports & Guidelines, others
1
Human Rights & the Right to Health
1
One Health
1
Policy
1
Diarrhoea
1
Situation Reports & Updates
1
Global Health Education
1
AR (African Region)
1
Education of students & professionals
1
Technical Information
1
Self-harm & Suicide
1
Clinical Guidelines
1
International
1
HIV / AIDS
1
Situation Reports
1
Travel Medicine
1
Anxiety Disorders
1
Tajikistan
1
HIV service delivery
1
Kazakhstan
1
MHPSS Guidelines
1
Learning Disabilities
1
South-east Asia Region
1
Laboratory
1
Paediatrics
1
Marburg Virus Situation Reports
1
Epidemiology
1
Action Plans, Policies & Response
1
Situation Reports, others
1
Mental Health GAP Action Programme
1
Training & Capacity Building
1
Treatment & Clinical Management
1
An Action Framework and annexe to Immunization Agenda 2030 (Draft version)
27 January 2021
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with...
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial drug resistance of Plasmodium falciparum parasites in Africa. Its objectives are to: i...
Parasites & Vectors volume 15, Article number: 389 (2022)
Dengue is one of the common arboviral infections and is a public health problem in South East Asia. The aim of this systematic review and meta-analysis was to evaluate the prevalence and distribution of dengue in SAARC (South Asian Associ...
Antimicrobial resistance (AMR) is a threat to global health and development and it contributes to millions of deaths worldwide each year. Inappropriate use and overuse of antibiotics are driving an increase in AMR and have a detrimental impact on the effectiveness of these critical medicines. Throug...
Although Shiga toxin-producing Escherichia coli (STEC) have been isolated from a variety of food production animals, they are most commonly associated with ruminants from which we derive meat and milk. Because of the widespread and diverse nature of ruminant-derived food production, coupled with the...
Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency assays have been used to estimate incidence in representative cross-sectional surveys and in epidemiological studies to better understand the pat...
This Mpox SPRP Global Monitoring & Evaluation (M&E) Framework, also referred to as the Framework, aims to monitor and report on global progress towards these objectives, including information about country-level response efforts and WHO support to Member States. Regular collection and analysis of da...
Despite the significant role of vector control in national leishmaniasis control programmes, the programmatic community perceives vector control as the weakest component of leishmaniasis control strategies in terms of resources, scientific evidence of the usefulness of interventions and capacity for...
WHO needs US$2.54 billion to provide life-saving assistance to millions of people around the world facing health emergencies. WHO’s Health Emergency Appeal is a consolidation of WHO’s priorities and financial requirements for 2023 to carry out health interventions in emergency and humanitarian r...
This chapter discusses the antibacterial treatment of leprosy infections. Antibiotic treatment is
a key component of leprosy treatment, as it is vital to prevent the progression of the infection.
Treatment with rifampin and other antibiotics is highly effective and cures 98% of patients with
the ...
Epidemiological Update
Dengue
7 February 2020
Situation summary
In the Region of the Americas, between epidemiological week (EW) 1 and EW 521 of 2019, a total of 3,139,335 cases of dengue have been reported (321.58 cases per 100,000 population), including 1,538 deaths. Of the total cases, 1,367,...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
Human African trypanosomiasis (HAT) has been an alarming global public health issue. The disease affects mainly poor and marginalized people in low-resource settings and is caused by two subspecies of haemoflagellate parasite, Trypanosoma brucei and transmitted by tsetse flies. Progress made in HAT ...
This technical report presents the epidemiology of human and animal leishmaniases in the EU and its neighbouring countries and concludes that the disease remains widespread and underreported in many countries of southern Europe, northern Africa, and the Middle East and that there is a need to improv...
In response to the recent publication “Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes” by Dadzie et al., it is important to clarify and highlight the positive and unequivocal research and operational contributio...
Several Public Health Services and general practitioners in the Netherlands observed an increase in scabies in the Netherlands. Since individual cases of scabies are not notifiable in the Netherlands, the epidemiological situation is mostly unknown. To investigate the scabies incidence in the Nether...
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr...
The epidemiology of the disease is mediated by the interaction of the parasite (trypanosome) with the vectors (tsetse flies), as well as with the human and animal hosts within a particular environment. Related to these interactions, the disease is confined in spatially limited areas called “foci...
Regional implementation framework for elimination of cervical cancer as a public health problem: 2021–2030
recommended
Cervical cancer continues to be a significant public health problem and a major cause of premature mortality among women, disproportionately affecting the socioeconomically disadvantaged population in low- and middle-income countries (LMICs). In the absence of implementing the known evidence-based, ...
